eagle-i Harvard UniversityHarvard University
See it in Search

Technology Transfer (McLean Hospital)

Location: 115 Mill Street, Belmont, MA 02478-9106

Summary:

Technology Transfer at McLean is handled within Research Administration by the Senior Associate Director of Technology Transfer, working as an adjunct to Partners Healthcare Office of Research Ventures and Licensing (RVL). McLean.s Senior Associate Director of Technology Transfer is responsible for the identification and protection of new inventions and other commercially-valuable intellectual property that arises from McLean.s research and clinical activities. The Senior Associate Director also negotiates contracts and other research-related interactions between McLean staff and industry.

McLean investigators are covered by the Intellectual Property Policy for Partners-Affiliated Hospitals and Institutions. The purpose of this Policy is to promote the missions of the Partners Hospitals by making inventions, copyrightable works and other intellectual property that may be created by physicians, researchers, and trainees available for the benefit of the public while also providing for a fair allocation of the financial costs and rewards associated with them.

McLean staff members who believe they have made an invention in the course of their research or clinical practice should contact Research Administration and complete an Invention Disclosure Form. To avoid the possible loss of patent rights in key countries, staff members are strongly encouraged to consult with Research Administration well before publication or public presentation. For those inventions which the Hospital decides to pursue, McLean will seek patent protection and contact potential corporate partners and licensees at McLean.s expense. McLean's Senior Associate Director of Technology Transfer can also answer any questions you may have about patents or the patent process, or can refer you to additional information.

Research Administration should also be consulted before investigators enter into any agreements with pharmaceutical, biotechnology or medical device companies, or other industrial companies. This includes confidentiality agreements, material transfer agreements, consulting agreements, as well as agreements for the industrial sponsorship of clinical or nonclinical research.

Affiliations:

People:

      Member: Glass, David, Ph.D.
      Role: Director, Technology Transfer, Senior Associate Director, Technology Transfer McLean Hospital Research Administration

    Resources:

    Services

    • Industry agreements service ( Support service )

      "Research Administration must be consulted before investigators enter into legal agreements with industry or with other non-profit institutions, including confidentiality agreements, material transfer agreements, consulting agreements, as well as agreements for the industrial sponsorship of clinical or nonclinical research. Most of these agreements are negotiated on a case-by-case basis, often starting with a template agreement provided by the company.
      Please contact Research Administration if you are contemplating any relationship that may require an agreement between McLean and a company or another academic laboratory. However, if you wish to send McLean-developed reagents, antibodies, cell lines, or animal models to investigators at other non-profit institutions, Research Administration can allow such transfers to other academic labs to be handled by individual laboratories, using standard material transfer agreement forms that can be obtained from Research Administration. However, investigators should contact Research Administration if you wish to send any such materials to a for-profit company, or for any modifications to our standard form, or to initiate a research-related agreement of any other kind."

    • Invention consultation and patent protection ( Support service )

      "McLean staff members who believe they have made an invention in the course of their research or clinical practice should contact Research Administration and complete an Invention Disclosure Form. To avoid the possible loss of patent rights in key countries, staff members are strongly encouraged to consult with Research Administration well before publication or public presentation. For those inventions which the Hospital decides to pursue, McLean will seek patent protection and contact potential corporate partners and licensees at McLean.s expense. Our colleagues at MGH have posted some useful, basic information about patents and McLean.s Senior Associate Director of Technology Transfer can also answer any questions you may have about patents or the patent process, or can refer you to additional information. "

    • Technologies licensing service ( Access service )

      "McLean Hospital is home to the largest research facility in a psychiatric hospital, and produces many inventions that may be of benefit to the public or be licensable to healthcare providers and other third parties. McLean's inventions portfolio can be broken into [six] categories:

      * Alzheimer's Disease
      * Brain Imaging
      * Diagnostics of Psychiatric Disorders
      * Substance Abuse
      * Therapeutics of Neuropsychiatric Disorders
      * Other Inventions"


    Web Links:

    Last updated: 2011-07-26T11:40:43.469-05:00

    Copyright © 2016 by the President and Fellows of Harvard College
    The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016